Literature DB >> 27052345

Inhibition properties of propolis extracts to some clinically important enzymes.

Nimet Baltas1, Oktay Yildiz2, Sevgi Kolayli3.   

Abstract

The present study was conducted to envisage inhibition effects of propolis on the crucial enzymes, urease, xanthine oxidase (XO) and acetylcholinesterase (AChE). Some of the antioxidant properties of the propolis samples were determined using the total phenolic content (TPE) and total flavonoids in the eight different ethanolic propolis extracts (EPE) samples. Inhibition values of the enzymes were expressed as inhibition concentration (IC50; mg/mL or μg/mL) causing 50% inhibition of the enzymes with donepezil, acetohydroxamic acid and allopurinol as reference inhibitors. All the propolis extracts exhibited variable inhibition effects on these enzymes, but the higher the phenolic contents the lower the inhibitions values (IC50 = 0.074 to 1.560 mg/mL). IC50 values of the P5 propolis sample having the highest TPE, obtained from Zonguldak, for AChE, urease and XO were 0.081 ± 0.009, 0.080 ± 0.006 and 0.074 ± 0.011 μg/mL, respectively. The EPE proved to be a good source of inhibitor agents that can be used as natural inhibitors to serve human health.

Entities:  

Keywords:  Acetylcholinesterase; enzyme inhibition; propolis; urease; xanthine oxidase

Mesh:

Substances:

Year:  2016        PMID: 27052345     DOI: 10.3109/14756366.2016.1167049

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  3 in total

1.  Ethnomedicinal Uses of Honeybee Products in Lithuania: The First Analysis of Archival Sources.

Authors:  Zivile Pranskuniene; Jurga Bernatoniene; Zenona Simaitiene; Andrius Pranskunas; Tauras Mekas
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-25       Impact factor: 2.629

2.  Investigation of potential inhibitor properties of ethanolic propolis extracts against ACE-II receptors for COVID-19 treatment by molecular docking study.

Authors:  Halil Ibrahim Guler; Gizem Tatar; Oktay Yildiz; Ali Osman Belduz; Sevgi Kolayli
Journal:  Arch Microbiol       Date:  2021-05-05       Impact factor: 2.552

3.  Integrated in silico - in vitro strategy for the discovery of potential xanthine oxidase inhibitors from Egyptian propolis and their synergistic effect with allopurinol and febuxostat.

Authors:  Dina S Ghallab; Eman Shawky; Ali M Metwally; Ismail Celik; Reham S Ibrahim; Mohamed M Mohyeldin
Journal:  RSC Adv       Date:  2022-01-21       Impact factor: 3.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.